The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers

By Robertson J.F.R.   Jaeger W.   Syzmendera J.J.   Selby C.   Coleman R.   Howell A.   Winstanley J.   Jonssen P.E.   Bombardieri E.   Sainsbury J.R.C.   Gronberg H.   Kumpulainen E.   Blamey R.W.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

By Kyvernitakis I.   Knöll D.   Struck M.   Hars O.   Bauer T.   Hadji P.  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite

Editorial comment on ''Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer'' by Deurloo and colleagues

By Cornford E.   Evans A.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1037-1038

Elsevier

Access to resources Recommend Favorite

Breast cancer management in the elderly

By Luque M.   Arranz F.   Cueva J.   Juan A.   García-Teijido P.   Calvo L.   Peláez I.   García-Palomo A.   García-Mata J.   Antolín S.   García-Estévez L.   Fernández Y.  

Clinical and Translational Oncology, Vol. 16, Iss. 4, 2014-04 ,pp. : 351-361

Springer Publishing Company

Access to resources Recommend Favorite

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

By D’Alessandro R.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 1, 2001-07 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite